Vidofludimus is an orally administered small-molecule compound under investigation as an active pharmaceutical ingredient. It acts as a Nurr1 activator and DHODH inhibitor, and its calcium salt is being studied for chronic inflammatory and autoimmune conditions.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Vidofludimus?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
N-chloromethyl olanzapine chloride
pharmaceutical raw material
Dihydroartemisinin
pharmaceutical raw material
Α-artemether
pharmaceutical raw material
Artemether
pharmaceutical raw material
Vidofludimus-calcium
pharmaceutical raw material
The international HS code for Vidofludimus (CAS 717824-30-1) is 2924.29.
2924.29
2924 29 70
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-[[2-fluoro-4-(3-methoxyphenyl)phenyl]carbamoyl]cyclopentene-1-carboxylic acid
XPRDUGXOWVXZLL-UHFFFAOYSA-N
COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)O)F
Sourcing Vidofludimus?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.